Barclays Reiterates an 'Overweight' on ARIAD Pharmaceuticals (ARIA); Ponatinib Demonstrated Acceptable Safety Profile

Go back to Barclays Reiterates an 'Overweight' on ARIAD Pharmaceuticals (ARIA); Ponatinib Demonstrated Acceptable Safety Profile
Ariad Pharmaceuticals, Inc. (NYSE: ARIA) Delayed: 24.94 --0 (-0%)
Previous Close $24.94    52 Week High $14.34 
Open $24.94    52 Week Low $4.37 
Day High $24.94    P/E N/A 
Day Low $24.94    EPS $-1.45 
Volume